Stephen O’Hara, CEO of OptiBiotix, is a scientist with more than 50 publications, 60 patents and chapters in a number of books. Having worked in the health care and biotechnological industries for more than 30 years, he has a wealth of experience through previous directorship roles with major public and private companies, including the NHS and 3M. He founded life sciences company OptiBiotix in 2012 to develop compounds which modulate the human microbiome and deliver revolutionary health solutions.